We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
(+41%)
Cap. Flow
+$327M
Cap. Flow
% of AUM
38.29%
Top 10 Holdings %
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$13.6M |
| 2 |
Merck
MRK
|
+$12.5M |
| 3 |
Intuitive Surgical
ISRG
|
+$11.1M |
| 4 |
DOCU
DocuSign
DOCU
|
+$10.9M |
| 5 |
Insulet
PODD
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nasdaq
NDAQ
|
+$7.26M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$6.86M |
| 3 |
Incyte
INCY
|
+$6.31M |
| 4 |
Fidelity National Information Services
FIS
|
+$5.73M |
| 5 |
AbbVie
ABBV
|
+$4.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Consumer Discretionary | 17.68% |
| 3 | Healthcare | 16.13% |
| 4 | Industrials | 12.13% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
MongoDB
MDB
$30.6B
| $868K | 0.1% |
+2,510
| New | +$953K |
|
277
Aon
AON
$75.7B
| $866K | 0.1% |
2,672
-1,227
| -31% | -$406K |
|
278
Intercontinental Exchange
ICE
$83.8B
| $860K | 0.1% |
7,818
+4,344
| +125% | +$498K |
|
279
AerCap
AER
$24.4B
| $854K | 0.1% |
13,621
-4,240
| -24% | -$267K |
|
280
Dow Inc
DOW
$21.9B
| $852K | 0.1% |
+16,528
| New | +$887K |
|
281
Bread Financial
BFH
$4.54B
| $852K | 0.1% |
+24,911
| New | +$913K |
|
282
Louisiana-Pacific
LPX
$5.37B
| $851K | 0.1% |
15,394
+6,029
| +64% | +$396K |
|
283
Sonos
SONO
$1.94B
| $848K | 0.1% |
65,720
+52,311
| +390% | +$776K |
|
|
APLS
284
DELISTED
Apellis Pharmaceuticals
APLS
| $844K | 0.1% |
+22,188
| New | +$975K |
|
285
Toro Company
TTC
$9.44B
| $839K | 0.1% |
10,096
+4,838
| +92% | +$466K |
|
|
JKS
286
JinkoSolar
JKS
$837M
| $835K | 0.1% |
+27,509
| New | +$988K |
|
287
Broadridge
BR
$19.5B
| $833K | 0.1% |
+4,653
| New | +$824K |
|
288
Skywest
SKYW
$4.56B
| $833K | 0.1% |
+19,863
| New | +$833K |
|
289
CDW
CDW
$19.7B
| $830K | 0.1% |
4,116
+1,484
| +56% | +$296K |
|
290
Keysight
KEYS
$58.3B
| $824K | 0.1% |
+6,227
| New | +$922K |
|
|
DO
291
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $823K | 0.1% |
+56,073
| New | +$856K |
|
292
Caesars Entertainment
CZR
$6.14B
| $821K | 0.1% |
+17,703
| New | +$941K |
|
293
Eastman Chemical
EMN
$8.45B
| $819K | 0.1% |
+10,678
| New | +$886K |
|
294
Golar LNG
GLNG
$5.03B
| $816K | 0.1% |
+33,647
| New | +$776K |
|
295
Azenta
AZTA
$1.39B
| $806K | 0.09% |
+16,058
| New | +$807K |
|
296
Regeneron Pharmaceuticals
REGN
$78.3B
| $802K | 0.09% |
+975
| New | +$766K |
|
297
AutoZone
AZO
$49.4B
| $800K | 0.09% |
315
-320
| -50% | -$803K |
|
298
Delta Air Lines
DAL
$61B
| $796K | 0.09% |
21,509
-98,667
| -82% | -$4.28M |
|
299
Vipshop
VIPS
$7.49B
| $792K | 0.09% |
49,469
-18,913
| -28% | -$307K |
|
300
Wheaton Precious Metals
WPM
$52.4B
| $788K | 0.09% |
19,434
+8,012
| +70% | +$346K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.
- Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
- Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
- Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
- Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
- Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
- Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
- Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.
Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.